GAUDIO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 909
AS - Asia 739
EU - Europa 320
SA - Sud America 99
AF - Africa 61
OC - Oceania 2
Totale 2.130
Nazione #
US - Stati Uniti d'America 885
SG - Singapore 318
CN - Cina 280
DE - Germania 102
IT - Italia 100
BR - Brasile 75
MA - Marocco 50
VN - Vietnam 46
FR - Francia 33
PK - Pakistan 25
HK - Hong Kong 17
IN - India 16
GB - Regno Unito 14
PL - Polonia 11
CA - Canada 9
NL - Olanda 9
JP - Giappone 8
EC - Ecuador 7
FI - Finlandia 7
MX - Messico 7
AR - Argentina 6
ES - Italia 6
ZA - Sudafrica 6
ID - Indonesia 5
UA - Ucraina 5
AT - Austria 4
BZ - Belize 4
EE - Estonia 4
RU - Federazione Russa 4
TR - Turchia 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
CL - Cile 3
CO - Colombia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
SE - Svezia 3
AU - Australia 2
BD - Bangladesh 2
BG - Bulgaria 2
HU - Ungheria 2
IE - Irlanda 2
IQ - Iraq 2
KG - Kirghizistan 2
KR - Corea 2
LV - Lettonia 2
PE - Perù 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BO - Bolivia 1
DZ - Algeria 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
SV - El Salvador 1
UY - Uruguay 1
VE - Venezuela 1
Totale 2.130
Città #
San Jose 155
Singapore 150
Dallas 149
Ashburn 131
Frankfurt am Main 77
The Dalles 68
Chandler 61
Hefei 53
Casablanca 49
Beijing 45
Los Angeles 19
Boardman 17
Hong Kong 17
Bari 15
Islamabad 15
Hillsboro 14
Columbus 13
Hanoi 12
New York 12
Atlanta 10
Milan 10
Munich 10
Santa Clara 10
Warsaw 10
Ho Chi Minh City 9
Lawrence 9
Modugno 9
Orem 9
Princeton 9
Legnago 8
Chennai 7
Chicago 7
London 7
Boydton 6
Helsinki 6
Reston 6
São Paulo 6
Amsterdam 5
Boston 5
Da Nang 5
Marseille 5
Molfetta 5
Nuremberg 5
Tokyo 5
Casamassima 4
Guayaquil 4
Montreal 4
Seattle 4
Bitonto 3
Brooklyn 3
Brussels 3
Buffalo 3
Cairo 3
Johannesburg 3
Mammelzen 3
Scordia 3
Stockholm 3
Toronto 3
Adelfia 2
Belo Horizonte 2
Bishkek 2
Council Bluffs 2
Curitiba 2
Dubai 2
Dublin 2
Durban 2
Foggia 2
Haiphong 2
Ikegami 2
Las Vegas 2
Lima 2
Lomas de Zamora 2
Mexico City 2
Montalto Uffugo 2
New Delhi 2
Ninh Bình 2
Osasco 2
Padua 2
Prague 2
Quito 2
Riga 2
Rome 2
San Francisco 2
Secaucus 2
São Luís 2
Tashkent 2
Adapazarı 1
Addis Ababa 1
Agadir 1
Agronômica 1
Al Hillah 1
Algiers 1
Amman 1
Andria 1
Ankara 1
Antakya 1
Assaí 1
Astana 1
Baku 1
Barcelona 1
Totale 1.371
Nome #
Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma 59
Different spatial distribution of inflammatory cells in the tumor microenvironment of ABC and GBC subgroups of diffuse large B cell lymphoma 56
The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells 54
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 52
STAT3, tumor microenvironment, and microvessel density in diffuse large B cell lymphomas 52
Blastic Plasmocytoid Dendritic Cell Neoplasm (BPDCN): Clinical Features and Histopathology with a Therapeutic Overview 51
Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP) 51
STAT3, tumor microenvironment, and microvessel density in diffuse large B cell lymphomas 50
Tumor cell microenvironment and microvessel density analysis in MALT type lymphoma 49
Inflammatory Cells in Diffuse Large B Cell Lymphoma 49
Different patterns of mast cell distribution in B-cell non-Hodgkin lymphomas 47
Molecular Features and Diagnostic Challenges in Alpha/Beta T-Cell Large Granular Lymphocyte Leukemia 46
Plerixafor in association with R-DHAP and G-CSF to mobilize a large number of CD34 + cells in patients with relapsed-refractory diffuse large B-cell lymphomas 44
CT-guided needle biopsy performed with modified coaxial technique in patients with refractory or recurrent lymphomas 43
High Ki67 index and bulky disease remain significant adverse prognostic factors in patients with diffuse large B cell lymphoma before and after the introduction of rituximab 43
The Evolving Role of Cannabidiol-Rich Cannabis in People with Autism Spectrum Disorder: A Systematic Review 42
Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors: Evaluating Background Parenchymal Enhancement and Radiotherapy-Induced Toxicity 42
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients 42
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 41
Computer-driven quantitative image analysis in the assessment of tumor cell and T cell features in diffuse large B cell lymphomas 40
Brentuximab vedotin prior to allogeneic stem cell transplantation increases survival in chemorefractory Hodgkin's lymphoma patients 39
Bone Involvement in Hodgkin's Lymphoma: Clinical Features and Outcome 38
The Tumor Microenvironment in Classic Hodgkin’s Lymphoma in Responder and No-Responder Patients to First Line ABVD Therapy 37
Computed tomography-guided needle biopsy performed with modified coaxial technique in patients with suspected lymphoma 36
CD3+/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation 36
Sequencing Anti-CD19 Therapies in Diffuse Large B-Cell Lymphoma: From Mechanistic Insights to Clinical Strategies 36
Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma 36
Checkpoint Inhibition Followed by CAR-T Cell Therapy in Refractory PMLBCL: Immunologic Response and Fertility Preservation in a Young Patient 36
Extralymphatic Disease Is an Independent Prognostic Factor in Hodgkin Lymphoma 33
Prognostic Role of CDKN2A Deletion and p53 Expression and Association With MIPIb in Mantle Cell Lymphoma 33
Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas 33
CT-guided needle biopsy performed with modified coaxial technique in the diagnosis of malignant lymphomas 33
The Tumor Microenvironment in Classic Hodgkin’s Lymphoma in Responder and No-Responder Patients to First Line ABVD Therapy 32
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a retrospective analysis 31
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice 31
Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma 31
Tumor Microenvironment and Microvascular Density in Follicular Lymphoma 31
Pregnancy rate and outcome of pregnancies in long-term survivors of Hodgkin's lymphoma 30
Peripheral blood CD4/CD19 cell ratio is an independent prognostic factor in classical Hodgkin lymphoma 30
Long-term Hodgkin Lymphoma Survivors: A Glimpse of What Happens 10 Years After Treatment 30
Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life Experience 29
Outcomes of Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Hodgkin Lymphomas: A Retrospective Multicenter Experience by the Rete Ematologica Pugliese (REP) 29
The Tumor Microenvironment in Classic Hodgkin's Lymphoma in Responder and No-Responder Patients to First Line ABVD Therapy 29
Recovery of CMV-specific CD8(+) T cells and T regs after allogeneic peripheral blood stem cell transplantation 29
Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program 28
T cells, mast cells and microvascular density in diffuse large B cell lymphoma 28
The Role of Peptides in Nutrition: Insights into Metabolic, Musculoskeletal, and Behavioral Health: A Systematic Review 28
STAT3, tumor microenvironment, and microvessel density in diffuse large B cell lymphomas 28
Relapsing/refractory HL After Autotransplantation: Which Treatment? 28
Impact of Hematopoietic Stem Cell Transplantation on PD-1 Blockade Efficacy in Relapsed/Refractory Hodgkin’s Lymphoma 27
Subsets of CD34+ and early engraftment kinetics in allogeneic peripheral SCT for AML 26
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma 26
Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation 25
Breast Cancer Risk After Chest Radiotherapy in Hodgkin Lymphoma Survivors: A Comprehensive Overview 24
Intravascular Lymphoma: A Unique Pattern Underlying a Protean Disease 22
Microvascular density, CD68 and tryptase expression in human diffuse large B-cell lymphoma 22
Risk of lymphoma subtypes by occupational exposure in southern Italy 22
Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma 22
Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience 21
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 20
The Anti-Metastatic Role of Aspirin in Cancer: A Systematic Review 17
Genetic Alterations in Multiple Myeloma: Implications for Prognosis and Advances in Diagnostic Approaches 16
Targeting the Tumor Microenvironment in Hodgkin Lymphoma: Challenges and Therapeutic Strategies 16
Mechanisms of Action of Ready-to-Use Therapies in Hematologic Malignancies: From Clinical Impact to Future Directions 16
Totale 2.203
Categoria #
all - tutte 19.953
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.953


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202227 0 0 0 0 0 0 7 0 8 10 1 1
2022/2023134 18 0 0 24 13 24 0 10 30 1 14 0
2023/2024107 5 4 2 3 5 1 2 2 8 49 5 21
2024/2025398 6 20 17 21 40 81 12 31 53 17 62 38
2025/20261.537 56 192 117 243 89 66 311 157 142 164 0 0
Totale 2.203